BioCentury
ARTICLE | Company News

Zalicus, Epirus deal

July 21, 2014 7:00 AM UTC

Epirus completed its reverse merger with Zalicus, and the combined company, named Epirus Biopharmaceuticals Inc., began trading on NASDAQ under the ticker “EPRS” (see BioCentury, April 21 & July 14). ...